Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments
3d-printing-investing Organovo Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook
3d-printing-investing Organovo Announces Release Date for Fiscal Third-Quarter 2017 Financial Results
Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting
3d-printing-investing Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
3d-printing-investing Organovo Announces Release Date for Fiscal Second-Quarter 2017 Financial Results
3d-printing-investing Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
3d-printing-investing Organovo Presents Data Supporting 3D Bioprinted Liver Tissues for Drug Toxicity Testing and Liver Fibrosis Modeling
3d-printing-investing Organovo Holdings Announces Second Quarter 2016 Fiscal Results and Long-Range Outlooks
